Review of the quality monitoring methods used by countries using or implementing universal leukoreduction

References 

1. Engelfriet CP, Reesink HW, Schwartz DWM, et al.  Universal leukocyte-depletion of blood components (Cell concentrates and plasma). Vox Sang. 2001;81:56–77
   • MEDLINE
2. Bekanntmachung des Paul-Ehrlich-Instituts vom 18.08.2000 uber die Ergebnisse des Stufenplanverfahrens zur Einfuhrung der Leukozytendepletion von zellularen Blutprodukten zer Transfusion. 2000; Bundesanzeiger Nr. 174 v. 14.09.
3. Guide to the preparation, use and quality assurance of blood components. 8th Edition.. Strasbourg: France Council of Europe Publishing; 2002;
4. Dumont LJ, Rebulla P, Brandwein H. Practical Guidelines for process validation and process control of white cell-reduced blood components (Report of the Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion (ISBT)). Transfusion. 1996;36:11–20
5. Dzik WH. Leukocyte counting during process control of leukoreduced blood components. Vox Sang. 2000;78(suppl 2):223–226
6. van der Meer PF, Gratama JW, van Delden CJ, et al.  Comparison of five platforms for enumeration of residual leukocytes in leucoreduced blood components. Br J Haematol. 2001;115:953–962
   • MEDLINE
   • CrossRef
7. Cardigan R, Phipps A, Seghatchian J, et al.  The development of a national standardized approach for the enumeration of residual leukocytes in blood components. Vox Sang. 2002;83:100–109
   • MEDLINE
   • CrossRef
8. Beckman N, Seghatchian J. Leukoreduction process performance variation (Is it dependent on batch of filters, the processing center or counting technology?). Transfusion Sci. 2000;23:113–118
9. Barclay R, Walker B, Allan R, et al.  Flow cytometric determination of residual leukocytes in filter-depleted blood products (An evaluation of Becton-Dickinson’s LeucoCOUNT system). Transfusion Sci. 1998;19:399–403
10. Guidance for Industry: Pre-Storage Leukocyte Reduction of Whole Blood and Blood Components Intended for Transfusion. Draft. Rockville, MD: Food and Drug Administration; 2001; January. Available at: www.fda.gov/cber/guidelines.htm. Accessed October 1, 2003
11. Grant EL, Leavenworth RS. Statistical Quality Control. (ed 5).. New York, NY: McGraw-Hill; 1980;
12. Beckman N, Cardigan R, Wallington T, et al.  Value of central analysis of leukocyte depletion quality control data within the National Blood Service, England. Vox Sang. 2002;83:110–118
    • MEDLINE
    • CrossRef
13. Chabanel A, Andreu G, Carrat F, et al.  Quality control of leukoreduced cellular blood components. Proceedings of the BEST Meeting. 2000; Washington, November 2–3
14. Adams MR, Fisher DM, Dumont LJ, et al.  Detecting failed WBC-reduction processes (Computer simulations of intermittent and continuous process failure). Transfusion. 2000;40:1427–1433